Irinotecan Plus Raltitrexed as Second-line Treatment in Advanced Colorectal Cancer Patients
收藏NIAID Data Ecosystem2026-03-10 收录
下载链接：
https://www.omicsdi.org/dataset/ecrin-mdr-crc/2236701
下载链接
链接失效反馈官方服务：
资源简介：
Irinotecan and raltitrexed are active against advanced colorectal cancer (ACC), act through different mechanisms, and have only partially overlapping toxicity profiles. The purpose of this study is to evaluate efficacy and safety of irinotecan plus raltitrexed as second-line treatment in advanced colorectal cancer patients.
创建时间：
2016-12-15
